Cargando…
Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasion
p53 mutation is a marker of poor prognosis in breast cancers. To identify downstream targets of p53, we screened two transcriptome datasets, including cDNA microarrays of MCF10A breast epithelial cells with wild-type p53 or p53-null background, and RNA sequence analysis of breast invasive carcinoma....
Autores principales: | Yodsurang, Varalee, Tanikawa, Chizu, Miyamoto, Takafumi, Lo, Paulisally Hau Yi, Hirata, Makoto, Matsuda, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593524/ https://www.ncbi.nlm.nih.gov/pubmed/28915553 http://dx.doi.org/10.18632/oncotarget.18433 |
Ejemplares similares
-
Identification of a p53-repressed gene module in breast cancer cells
por: Miyamoto, Takafumi, et al.
Publicado: (2017) -
Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53
por: Miyamoto, Takafumi, et al.
Publicado: (2017) -
Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cells
por: Tsuda, Yusuke, et al.
Publicado: (2017) -
Cystatin C as a p53‐inducible apoptotic mediator that regulates cathepsin L activity
por: Mori, Jinichi, et al.
Publicado: (2016) -
Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway
por: Lothong, Muttarin, et al.
Publicado: (2021)